Kristen Hege
June 14, 2023 06:27 AM EDT
Bioregnum

Bris­tol My­ers of­fers a $100,000 vote of sup­port for Kris­ten Hege's ad­ven­tur­ous fundrais­ing cam­paign

Kris­ten Hege made quite a few friends in bio­phar­ma dur­ing her lengthy ca­reer in R&D. In ad­di­tion to play­ing a lead­ing role in ad­vanc­ing …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Ver­san­t's lat­est biotech fo­cus­es on in­flam­ma­to­ry dis­eases

Mer­ck is ‘well-po­si­tioned’ on Keytru­da ahead of threat­ened phar­ma tar­iffs, CEO says

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times